Connect with us

featured

Medical Marijuana Helps Most Patients Effectively Treat Chronic Pain, New Study Shows

Published

on


A new study on cannabis and chronic pain finds that more than 8 in 10 patients who used medical marijuana reported it to be a useful tool for pain management.

“This points to the possibility that cannabis could serve as a safer alternative or complement to standard pain management approaches, potentially helping to address the ongoing opioid crisis,” the study’s senior author—Ari Greis, an orthopedic surgery professor at Drexel University College of Medicine and a board member of the Rothman Institute Foundation for Opioid Research & Education—said in a statement about the findings.

Published this month in the journal Cureus, the report stems from a survey of 129 people who were medical marijuana patients in Pennsylvania between October 2022 and December 2024. It says it “provides important insights into the real-world patterns, perceived efficacy, and cognitive effects of medical cannabis use among individuals with chronic musculoskeletal pain who employ cannabis regularly over extended periods.”

“Over 80 percent of patients who turned to medical cannabis found it effective for managing their pain,” co-author Mohammad Khak, a researcher at the Rothman Opioid Foundation, said in a press release about the study.

“Many participants also noted improvements in associated symptoms such as sleep disturbances and anxiety,” Khak added, “suggesting that cannabis may offer a broader range of relief than conventional pain medications alone.”

The report says that the “majority of respondents expressed positive views on the effectiveness of cannabis in improving their main symptom, with 66 (51.1%) strongly agreeing and 55 (42.6%) agreeing with the statement.”

“Long-term [medical cannabis] use is a stable and well-tolerated option for managing chronic musculoskeletal pain.”

Few who were surveyed felt cannabis treatment was ineffective.

“A small portion of seven (5.4%) were neutral, neither agreeing nor disagreeing, and only one respondent (0.7%) disagreed,” the study says, “suggesting that most respondents find cannabis beneficial for symptom relief.”

As for mood, “the majority reported that it changed their mood for the better, while a smaller percentage experienced no impact or undesirable effects.”

The nonprofit Rothman Opioid Foundation is a group that aims to raise awareness of the opioid crisis, “educating physicians and patients on safe opioid prescribing and use, respectively, and advising policymakers on sound opioid and pain management policy,” the release says.

Most patients in the study (77.5 percent) reported using marijuana for more than two years, while 22.5 percent said they’d used it for between one and two years.

The most common frequency of dosage among patients was daily (27.9 percent), followed by two to three times per day (23.2 percent). A few patients (3.1 percent) reported using marijuana once a month or less.

Topicals were by far the most popular method of administration, reported by 63.5 percent of patients. Just under half (47.2 percent), meanwhile, reported “consistently using capsules, edibles, oils, or tinctures.”

“In contrast, more intense forms, such as concentrates (e.g., dabs, wax, and shatter), were used by only 12 respondents (9.3%),” the study says.

About eight in 10 patients also reported stable usage patterns over the prior three months, the research found, and most patients—and those around them—felt comfortable with the amount and frequency of their cannabis use.

“When asked if they had ever felt the need to cut back on cannabis use while treating their main symptom, 111 of the respondents (86%) reported no such inclination, while a small proportion of seven (5.4%) indicated that they did feel the need to reduce their use,” authors wrote. “Similarly, when asked if others had ever suggested cutting back on their cannabis use, an overwhelming majority of 128 (99.2%) responded negatively, with only one respondent (0.8%) reporting that they had received such a suggestion.”

“These findings suggest that most individuals do not perceive a need to limit their cannabis use for symptom management,” they added, “nor do they commonly face external recommendations to do so.”

“High levels of perceived efficacy were reported, with over 93% of respondents agreeing or strongly agreeing that [medical cannabis] improved their primary symptoms.”

Notably, about half of patients (46.5 percent) said they didn’t know their typical dosage of THC, while 47.2 percent didn’t know the amount of CBD they consumed.

Among those who did have a sense of dosage, the “median THC/CBD dose taken by mouth was 10 mg, while most respondents take smaller doses, with a few outliers skewing the mean higher than the median.”

More than seven in 10 patients (72.1 percent) said their use of cannabis had “no effect on their cognitive or motor functions,” according to the study. “A smaller proportion of 16 respondents (12.4%) experienced worse thinking and coordination but noted improvement in their symptoms.”

“Conversely, 17 (13.2%) indicated worse thinking and coordination without any noticeable effect on their overall day,” it continues. “Only three (2.3%) expressed dissatisfaction, reporting worse thinking and coordination, and disliking the effect entirely.”

Authors said the findings underscore “the diverse responses to cannabis and the importance of individualized assessments in understanding its impact on cognitive and motor functions.”

Separate research published last month by Cureus found that CBD helped patients manage chronic pain even at low dosages, making it “a promising alternative to conventional pain management strategies.”

Most patients reported no side effects, while those who did reported only mild effects, the report says. No severe side effects were reported.

“These findings suggest that CBD may serve as a promising alternative to conventional pain management strategies,” that study concluded. “We believe these data point the way for new and continued avenues of research that can better optimize treatment regimens and help patients with chronic pain.”

Past research has suggested that a variety of cannabinoids—including CBD and others—may help ease pain symptoms. A study published in February, for example, found that marijuana and its cannabinoid components may be useful treatments for various types of chronic pain, in some cases helping to reduce the use of other medications

The paper also said select mixtures of cannabinoids—such as cannabichromene (CBC) and cannabigerol (CBG)—could have other benefits, including minimizing undesirable effects like the psychoactivity of THC.

All told, more than 180 different cannabinoids have now been isolated from the cannabis plant, the report noted, often interacting with different parts of the body. CBD and THC, for example, “have a wide potential for therapeutic effects based on their multiple molecular targets including ion channels, receptors, transporters and enzymes.”

“The two most abundant and studied cannabinoids, THC and CBD, along with an understudied cannabinoid, cannabigerol (CBG), have been shown, in our laboratories, to reduce neuropathic pain in animal models,” authors wrote, recommending that further study “into cannabinoids like THC, CBD and CBG should focus on the optimal therapeutic doses and the effects these cannabinoids can have on the management of chronic neuropathic pain in humans.”

Separate research published earlier this year in the journal Pain found that marijuana was “comparatively more effective than prescription medications” for treating chronic pain after a three-month period, and that many patients reduced their use of opioid painkillers while using cannabis.

The analysis “was able to determine, using causal inference techniques, that use of medical marijuana for chronic pain under medical supervision is at least as effective and potentially more effective in relationship to patients with chronic pain treated by prescription medications (nonopioid or opioid),” said the report, by authors at the University of Pittsburgh, Harvard Medical School and the National Cancer Institute.

A recent federally funded study, meanwhile, found that legalization of marijuana in U.S. states is associated with reduced prescriptions for opioid pain medications among commercially insured adults—indicating a possible substitution effect where patients are choosing to use cannabis instead of prescription drugs to treat pain.

“These results suggest that substitution of cannabis for traditional pain medications increases as the availability of recreational cannabis increases,” authors of that report wrote, noting that there “appears to be a small shift once recreational cannabis becomes legal, but we see stronger results once users can purchase cannabis at recreational dispensaries.”

“Reductions in opioid prescription fills stemming from recreational cannabis legalization may prevent exposure to opioids in patients with pain,” the paper, published in the journal Cannabis, continues, “and lead to decreases in the number of new opioid users, rates of opioid use disorder, and related harms.”

Other recent research also showed a decline in fatal opioid overdoses in jurisdictions where marijuana was legalized for adults. That study found a “consistent negative relationship” between legalization and fatal overdoses, with more significant effects in states that legalized cannabis earlier in the opioid crisis. Authors estimated that recreational marijuana legalization “is associated with a decrease of approximately 3.5 deaths per 100,000 individuals.”

“Our findings suggest that broadening recreational marijuana access could help address the opioid epidemic,” that report said. “Previous research largely indicates that marijuana (primarily for medical use) can reduce opioid prescriptions, and we find it may also successfully reduce overdose deaths.”

“Further, this effect increases with earlier implementation of [recreational marijuana legalization],” it added, “indicating this relationship is relatively consistent over time.”

Another recently published report into prescription opioid use in Utah following the state’s legalization of medical marijuana found that the availability of legal cannabis both reduced opioid use by patients with chronic pain and helped drive down prescription overdose deaths statewide. Overall, results of the study indicated that “cannabis has a substantial role to play in pain management and the reduction of opioid use,” it said.

Yet another study, published in 2023, linked medical marijuana use to lower pain levels and reduced dependence on opioids and other prescription medications. And another, published by the American Medical Association (AMA) last February, found that chronic pain patients who received medical marijuana for longer than a month saw significant reductions in prescribed opioids.

About one in three chronic pain patients reported using cannabis as a treatment option, according to a 2023 AMA-published report. Most of that group said they used cannabis as a substitute for other pain medications, including opioids.

Other research published that year found that letting people buy CBD legally significantly reduced opioid prescription rates, leading to 6.6 percent to 8.1 percent fewer opioid prescriptions.

A 2022 research paper that analyzed Medicaid data on prescription drugs, meanwhile, found that legalizing marijuana for adult use was associated with “significant reductions” in the use of prescription drugs for the treatment of multiple conditions.

A 2023 report linked state-level medical marijuana legalization to reduced opioid payouts to doctors—another datapoint suggesting that patients use cannabis as an alternative to prescription drugs when given legal access.

Researchers in another study, published last year, looked at opioid prescription and mortality rates in Oregon, finding that nearby access to retail marijuana moderately reduced opioid prescriptions, though they observed no corresponding drop in opioid-related deaths.

Other recent research also indicates that cannabis may be an effective substitute for opioids in terms of pain management.

A report published recently in the journal BMJ Open, for instance, compared medical marijuana and opioids for chronic non-cancer pain and found that cannabis “may be similarly effective and result in fewer discontinuations than opioids,” potentially offering comparable relief with a lower likelihood of adverse effects.

Separate research published found that more than half (57 percent) of patients with chronic musculoskeletal pain said cannabis was more effective than other analgesic medications, while 40 percent reported reducing their use of other painkillers since they began using marijuana.

In Minnesota, meanwhile, a state government report this year on chronic pain patients enrolled in the state’s medical marijuana program said recently that participants “are finding a noticeable change in pain relief” within a few months of starting cannabis treatment.

The large-scale study of nearly 10,000 patients also shows that nearly a quarter who were taking other pain relievers reduced the use of those drugs after using medical marijuana.

Another new study on the use of medical marijuana by older patients—age 50 and above—concluded that “cannabis seemed to be a safe and effective treatment” for pain and other conditions.

A separate presentation reviewing research on student athletes’ use of cannabis recently found that marijuana “has demonstrated positive findings as an alternative for pain management among NCAA athletes.”

Yet another study found that 40 percent of military veterans suffering from chronic pain reported using marijuana to treat their symptoms.

Most of them said they use cannabis to deal with pain, mobility and sleep issues, while substantial numbers of veterans also said it helps with PTSD, anxiety and stress. Nearly all participants (98 percent) said healthcare providers should discuss the use of natural products with their patients.

Medical Marijuana Could Increase Efficacy Of Chemotherapy To Fight Cancer While Reducing Side Effects, Study Suggests

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Become a patron at Patreon!





Source link

mscannabiz.com
Author: mscannabiz.com

MScannaBIZ for all you Mississippi Cannabis News and Information.

featured

New Jersey Lawmakers Consider Recriminalizing Some Marijuana Purchases And Sales

Published

on


“People with cancer or chronic pain disability could be arrested simply for accessing a plant that helps them survive. Recriminalization is not regulation. It’s retaliation.” 

By Sophie Nieto-Muñoz, New Jersey Monitor

Lawmakers mulled Thursday whether New Jersey should ramp up enforcement against unlicensed cannabis sellers by passing a bill that would criminalize the purchase of unlicensed marijuana.

The bill riled cannabis activists, who say it would bring back the criminalization of weed that New Jersey’s marijuana legalization law was supposed to end. 

Under the bill, sponsored by Senate President Nick Scutari (D-Union), it would be a third-degree crime to operate an unlicensed marijuana business and a disorderly persons offense to knowingly purchase from one. A person who leads an “illegal marijuana business network” would be charged with a second-degree crime. 

“We have a problem where people are opening up brick-and-mortar stores, small stores, unlicensed to sell these products, and quite frankly, they’re just selling them and this state is doing nothing about it,” Scutari told the Senate Judiciary Committee Thursday. “We need to do something more about those brick-and-mortar stores, but we also need to continue to fight back against drug dealers because those are alive and well.” 

Scutari spearheaded legalizing recreational cannabis, first introducing legislation to regulate it for adult use in 2014. After bills languished in the Legislature, recreational cannabis was legalized in 2020 by voters, and Scutari was the primary sponsor of the bill to launch the legal marijuana industry.

Scutari said the new legislation would be a corrective measure in response to the “black and gray market” that has flourished even though hundreds of cannabis dispensaries have opened statewide.

New Jersey has some of the most expensive cannabis in the nation for both medical and recreational users. The industry has raked in over $1 billion since sales launched in April 2022. 

The committee did not vote on the bill, which does not yet have a companion in the Assembly.

Lawmakers generally voiced support for Scutari’s proposal to address the unlicensed THC products that they say undermine the regulated industry. Sen. Joe Lagana (D-Bergen) said he’s seen questionable cannabis products in “every single gas station I walk into, every convenience store, every corner store.”

But senators also repeatedly placed blame on the Attorney General’s Office, accusing it of not enforcing the state’s cannabis laws.

Sen. Mike Testa (R) blasted Attorney General Matt Platkin (D) for what he called “absentee” leadership. And Sen. Jon Bramnick (R-Union) said that once certain laws aren’t enforced, the community “loses respect for government.” Bramnick suggested the committee should call on Platkin to appear before them on the issue and said ignoring the law is “disrespectful to this body.”

A spokesperson for Platkin did not respond to requests for comment. 

Cannabis advocates who helped usher in the recreational market criticized Scutari’s bill as a dangerous reversal. One of them, attorney Bill Caruso, told committee members they need to speak to local mayors and law enforcement about the tools they need to fight against unlicensed cannabis sales.

“We don’t need to reinvent the wheel here, and I don’t think we need to go backwards in recriminalizing particularly consumers,” he said. 

He also agreed that the attorney general “needs to explain to the elected officials of this body” why laws aren’t being enforced

Larry Grant is a cancer survivor who takes cannabis for chronic pain and is a board member of the Coalition for Medical Marijuana. Grant called the bill “deeply unethical” and “the opposite” of what legalization set out to achieve. 

“People with cancer or chronic pain disability could be arrested simply for accessing a plant that helps them survive,” he said. “Recriminalization is not regulation. It’s retaliation.” 

Scutari said he’s open to changes to the bill, but establishing the crimes of selling and, in some cases, purchasing unlicensed marijuana “is necessary in order to drive people to a place where they can buy it legally.” 

“We would not accept the corner store that didn’t have a liquor license to sell liquor. We should not accept the corner store selling cannabis product without a license, nor should we accept people selling it out of their garage,” he said. “We have a legal marketplace now, and there are good reasons for it because it is safe for people to ingest that product.”

This story was first published by New Jersey Monitor.

Trump Administration Still Hasn’t Decided On Challenging Marijuana And Gun Rights Case, Getting More Time From Supreme Court

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Become a patron at Patreon!





Source link

mscannabiz.com
Author: mscannabiz.com

MScannaBIZ for all you Mississippi Cannabis News and Information.

Continue Reading

featured

Nebraska Governor’s Medical Marijuana Commission Picks Who Opposed Legalization Have Been Officially Confirmed

Published

on


“The patients of this state may be weary, may be tired, but they stand strong and will hold lawmakers accountable for their votes. They have the blood of Nebraskans on their hands.”

By Zach Wendling, Nebraska Examiner

Lawmakers approved the governor’s two appointees to the Nebraska Medical Cannabis Commission on Friday over opposition from long-term advocates that the new members could delay or derail the rollout of the voter-approved medicine.

In separate votes, the Legislature approved the six-year commission appointments of Dr. Monica Oldenburg of Lincoln, an anesthesiologist, and Lorelle Mueting of Gretna, prevention director for Heartland Family Service.

Oldenburg’s confirmation vote was 34-11. Mueting’s was 27-16.

The two appointees needed at least 25 votes to be confirmed. Had one or both been rejected, Gov. Jim Pillen (R) could still appoint someone else in the interim, without a legislative vote until 2026, or the same person if he chose.

Much of Friday’s debate on the confirmations, about 30 minutes for each nominee, revolved around whether the personal views of each woman could be separated from their new professional roles. For multiple years, Mueting and Oldenburg have opposed medical cannabis legislation at the State Capitol, including Mueting earlier this year.

Those legislative efforts were often supported by Nebraskans for Medical Marijuana and other long-time advocates who, in November, succeeded after a decade of pushing to legalize and regulate the medicine, often facing pushback from top state officials.

Appointee support and positions

The 71 percent voter approval for legalization and 67 percent for regulations also created the new state regulatory commission that Mueting and Oldenburg will now join. They will serve with the three commissioners on the Nebraska Liquor Control Commission, per the ballot measure.

Those commissioners are Bruce Bailey of Lincoln and Kim Lowe of Kearney, with one vacancy still to be filled by Pillen to represent Nebraska’s 2nd Congressional District.

State Sen. Rick Holdcroft of Bellevue, the chair of the Legislature’s General Affairs Committee that advanced Oldenburg 5-2 and Mueting 5-3, called the two candidates highly qualified.

He said Oldenburg’s extensive experience, combined with deep concern for the health, safety and overall well-being of Nebraskans through her 18 years of medical service, would shine. Holdcroft added that Mueting had a strong record of promoting public health issues while thoughtfully balancing public health goals with public safety considerations.

Multiple senators, including State Sen. Jared Storm of David City, said the two would make a great team and keep Nebraska focused on medicine, not recreational marijuana.

“I honestly don’t know of two better people to be on this board,” Storm said Friday.

Mueting had said last week that her goal as a prevention specialist for 24 years has been to prevent people from having substance use problems and that she’s looked at medical cannabis from a “360-degree view.”

“Helping to guide the rulemaking process around the needs of the people it’s intended to serve is my goal,” Mueting said. “There’s nothing about that goal that says we need to sacrifice public health and safety to attain it.”

Oldenburg said last week that she is “not a prohibitionist” of cannabis but is “pro-research.” She said cannabis has “a place in pain management” for certain ailments that cause suffering.

“Nebraska needs to seize the opportunity to be slow and deliberate in the manner in which we determine how best to designate appropriate conditions for medical cannabis and regulate those entities that will dispense medical cannabis in our state,” Oldenburg said. “I look forward to working with various parties to ensure that we in the State of Nebraska get this right.”

‘It’s about trust’

State Sen. Ben Hansen of Blair, who like Storm is a Republican, opposed Mueting but supported Oldenburg. Hansen brought Legislative Bill 677 earlier this year to set clearer medical cannabis regulations and guardrails with the backing of volunteers from the 2024 campaign.

LB 677 fell 10 votes short of advancing on May 20, the opposition of which Storm led. Mueting testified against the bill in March.

Hansen said he was concerned about Mueting’s impartiality and that lawmakers shouldn’t appoint someone who believes in prohibition to the Liquor Control Commission or someone who works for PETA to the Nebraska Brand Committee.

He said the same goes for someone to the Medical Cannabis Commission who “denies the legitimacy of medical cannabis to the very body tasked with implementing this regulation.”

“This isn’t just about professional qualifications,” Hansen said. “It’s about trust. Trust in the will of the voters. Trust in the integrity of this new commission and trust that we are putting the right people in place to carry out a law passed and overwhelmingly supported.”

State Sen. John Cavanaugh of Omaha, vice chair of the Legislature’s General Affairs Committee, said that while both Mueting and Oldenburg might be nice people, he was worried about “artificial hurdles.” He supported LB 677 partly because it would have set a path toward “access.”

The Medical Cannabis Commission is charged “exclusively” with the power to regulate the control of the possession, manufacture, distribution, delivery and dispensing of cannabis for medical purposes in the state. Rules and regulations for medical cannabis dispensaries are due July 1 under the voter-approved laws. Licensing is supposed to begin by Oct. 1.

LB 677 supporters and other advocates had voiced concerns that the Medical Cannabis Commission could craft regulations that prevent meaningful “access.”

Nebraska Attorney General Mike Hilgers (R) has already vowed to sue the commission if it issues any medical cannabis licenses. He argues it is against federal law.

‘Slow-roll access for patients’

Hansen said the public is paying attention, noting that the remaining dozens of gubernatorial appointments that lawmakers considered over the past five months, lawmakers had received 21 online comments.

But for Mueting and Oldenburg combined, lawmakers had 208 online comments, Hansen said.

Crista Eggers, executive director of Nebraskans for Medical Marijuana, said the Legislature again threw a “wrench” in the will of Nebraska voters. She criticized senators who used the ballot measures as a reason to oppose Hansen’s LB 677 but then voted to confirm appointees who “will slow-roll access for patients in this state.”

Eggers said the mission continues to be on patients, as it has been “from day one,” despite what some legislative opponents say.

“The representatives in the state that have misrepresented our mission will see their day where the people hold them accountable. Mark our words,” Eggers said in a statement. “The patients of this state may be weary, may be tired, but they stand strong and will hold lawmakers accountable for their votes. They have the blood of Nebraskans on their hands.”

This story was first published by Nebraska Examiner.

Texas House Rejects Senate’s Changes To Medical Marijuana Program Expansion Bill

 

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Become a patron at Patreon!





Source link

mscannabiz.com
Author: mscannabiz.com

MScannaBIZ for all you Mississippi Cannabis News and Information.

Continue Reading

featured

Texas Hemp Product Ban Would Devastate A Key Sector Of The State’s Agriculture Industry, Farmers Tell Lawmakers

Published

on


“Throw the lowlifes in jail if you want to stop the bad actors… Don’t take out the ag producers.”

By Jayme Lozano Carver, The Texas Tribune

Six years ago, Texas lawmakers opened a door to a new lifeline for farmers: growing hemp. Farmers invested time, money and land into growing the drought-resistant crop and developing the state’s budding hemp industry.

The same lawmakers are now slamming the door shut. All products containing tetrahydrocannabinol, or THC, could soon be banned in Texas. As a result, farmers are bracing for impact as they wait to go out of business.

“We wouldn’t be in the hemp business in a million years if they hadn’t passed that bill,” said Ann Gauger, co-owner of Caprock Family Farms in Lubbock. “Now we’re one of the largest hemp producers in the U.S., and their ban is going to shut that down.”

The Texas hemp industry, in its current form, has effectively been handed a death sentence with the upcoming passage of Senate Bill 3, authored by Lubbock Republican Sen. Charles Perry. On Sunday, the Legislature sent the bill, which bans consumable hemp products that contain even trace amounts of THC, to Gov. Greg Abbott‘s (R) desk. However, hemp can’t be produced without traces of THC, farmers say, regardless of the product.

The plant has been a target for lawmakers since the start of the legislative session, with the charge led by Lt. Gov. Dan Patrick (R). Patrick pulled out all the stops to make the ban pass, including with surprise visits to dispensaries in Austin and vows for a special session if it failed. Patrick and Perry say the hemp industry exploited a loophole in the bill that did not establish a threshold for hemp derivatives, other than delta-9 THC.

Texas Agriculture Commissioner Sid Miller has also walked back his opposition to an outright ban on THC, now aligning with Patrick’s position. He deleted a post on X where he called the THC ban a “sledgehammer” to farmers, and now Miller said the bill will not be detrimental to farmers. Miller said the hemp industry will thrive as it’s moving toward producing industrial hemp, a fiber type of hemp that does not contain THC. It could be used in construction materials, rope and more. He said they never intended to have THC available across Texas, and called it a dangerous situation.

“This just puts us back to where we started,” Miller told The Texas Tribune. “It’s going to be detrimental to a lot of businesses that have opened their business model on selling THC products. Those businesses will have to shut.”

In lawmakers’ pursuit of a ban, growers like Gauger were caught in the crosshairs. Gauger, who runs the business with her husband and two sons, felt ignored by most of the Legislature. Gauger says they did everything they could to get lawmakers to hear them over the last few months and testified to the House committee overseeing the bill. It did not work.

“Charles Perry says he has an open door policy. That is an absolute lie,” Gauger said. “We live in his district, and he will not see us. We’ve gone to his office in Austin, but he refuses to see us.”

Gauger said House Speaker Dustin Burrows (R-Lubbock), and his team were the only ones to speak with the family. Kyle Bingham is another frustrated hemp grower in the South Plains that took a chance on growing the crop. Bingham, who is also president of the Texas Hemp Growers Association, called the bill overreaching and unenforceable. He also said lawmakers involved in writing the bill ignored farmers during the process. Bingham is one of Perry’s constituents.

“We were left out of this conversation,” Bingham said. “Yes, you can go to public hearings, but not having a lot of say and being stonewalled out of the initial bills was frustrating.”

Throughout the session, Patrick has rallied against THC products, saying the products put children in danger. Gauger acknowledges there are bad actors in the industry, but says the bill will have a ripple effect. The industry also includes manufacturers, hemp processors and people to run extractors.

“Throw the lowlifes in jail if you want to stop the bad actors,” Gauger said. “But don’t take out the American farmers. Don’t take out the ag producers.”

Under the legislation, adults would face up to a year in jail for possessing hemp products with any amount of THC in it. This has put a stop to all of Gauger’s plans—the family farm was set to plant a large project that would produce 20 million pounds of CBD biomass. Since CBD is produced from hemp seeds, Gauger is worried she would be breaking the law. It wouldn’t be ready for harvest until October, a month after the law goes into effect.

“We would be felons if we planted that,” Gauger said. “The land’s already been prepped, herbicides already put out. Once you do that, you can’t plant anything else on that land for the season.”

Bingham is in a similar position. He uses about 5 percent of his 2,000-acre farm for hemp, but he saw it as a good alternative in the drought-ridden region. Now, he says he has to walk away from his investment if it’s illegal to possess any detectable amounts of THC in the field.

“At this point, they’re threatening a felony so I’m out,” Bingham said. “I’m not risking a felony over this, and I think most farmers in Texas will stop growing too.”

Bingham said he’s now considering what to do in September when the bill is slated to go into effect. Any products he still has with THC will either have to be sold by then or he will be burning it. He’s going to focus more on cotton and wheat, even though he wanted hemp to be in their rotation of crops.

Gauger is expecting a downfall for the hemp industry across Texas. Just like growers have to consider the legal consequences, the same applies for retailers and grocery stores that sell consumable hemp products. This includes hemp hearts, hemp seed oil and even some big brands—KIND bars have a line of granola bars that contain hemp seeds.

Perry’s team did not respond to a request to comment.

This article originally appeared in The Texas Tribune at https://www.texastribune.org/2025/05/26/texas-hemp-thc-ban-farmer/.

The Texas Tribune is a member-supported, nonpartisan newsroom informing and engaging Texans on state politics and policy. Learn more at texastribune.org.

Trump Administration Still Hasn’t Decided On Challenging Marijuana And Gun Rights Case, Getting More Time From Supreme Court

Photo courtesy of Brendan Cleak.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Become a patron at Patreon!





Source link

mscannabiz.com
Author: mscannabiz.com

MScannaBIZ for all you Mississippi Cannabis News and Information.

Continue Reading
video2 hours ago

Nebraska senators question medical marijuana commission appointees

featured3 hours ago

New Jersey Lawmakers Consider Recriminalizing Some Marijuana Purchases And Sales

video3 hours ago

Spanish police discover 2,000 marijuana plants growing inside greenhouses

video5 hours ago

Cannabis Law Now Podcast – The 4-1-1 on Cannabis Receiverships from a Top Cannabis Receiver | Husch Blackwell LLP

featured5 hours ago

Nebraska Governor’s Medical Marijuana Commission Picks Who Opposed Legalization Have Been Officially Confirmed

video6 hours ago

Kentucky breaks ground on state's first medical cannabis safety compliance facility

featured6 hours ago

Texas Hemp Product Ban Would Devastate A Key Sector Of The State’s Agriculture Industry, Farmers Tell Lawmakers

video7 hours ago

WATCH: Cannabis Expo comes to Johannesburg [VIDEO]

featured18 hours ago

Texas City’s Marijuana Decriminalization Law Saved Nearly Half A Million Dollars As Arrests Plummeted, Report Shows

featured19 hours ago

Trump Administration Still Hasn’t Decided On Challenging Marijuana And Gun Rights Case, Getting More Time From Supreme Court

video20 hours ago

Historic AC church to be demolished to make way for cannabis dispensary – NBC10 Philadelphia

featured20 hours ago

It’s Time For Pennsylvania Senate GOP To Get Serious About Marijuana, Sponsor Of House-Passed Legalization Bill Says (Op-Ed)

video21 hours ago

54 pounds of marijuana found luggage at Pittsburgh International Airport

featured22 hours ago

Texas House Rejects Senate’s Changes To Medical Marijuana Program Expansion Bill

video22 hours ago

Smoke it or eat it, cannabis is bad for your heart, new research shows

Delivered Inc.22 hours ago

Delivered Inc.: A dispensary at your doorstep

featured23 hours ago

Fun Things To Do After Consuming Marijuana

video23 hours ago

UCSF Study reveals risk tied to cannabis consumption

featured24 hours ago

Oregon Cannabis Companies No Longer Need Labor Peace Agreements to Renew Licenses

video24 hours ago

One question dogs Pennsylvania’s cannabis debate: Should big businesses have a leg up?

20251 day ago

Star signs and cannabis strains: June 2025 horoscopes

featured1 day ago

Colorado Psychedelics Program Primed for Launch

video1 day ago

Haribo recalls sweets in the Netherlands after cannabis detected

featured1 day ago

Minnesota Governor Signs Bill To Decriminalize Bong Water Containing Drug Residue

Breaking News1 year ago

Connecticut Appoints The US’s First Cannabis Ombudsperson – Yes there is a pun in there and I’m Sure Erin Kirk Is Going To Hear It More Than Once!

best list10 months ago

5 best CBD creams of 2024 by Leafly

California Cannabis Updates1 year ago

Alert: Department of Cannabis Control updates data dashboards with full data for 2023 

Bay Smokes11 months ago

Free delta-9 gummies from Bay Smokes

cbd1 year ago

New Study Analyzes the Effects of THCV, CBD on Weight Loss

Mississippi Cannabis News1 year ago

Mississippi city official pleads guilty to selling fake CBD products

Business8 months ago

EU initiative begins bid to open access to psychedelic therapies

California1 year ago

May 2024 Leafly HighLight: Pink Runtz strain

Breaking News1 year ago

Curaleaf Start Process Of Getting Their Claws Into The UK’s National Health System – With Former MP (Resigned Today 30/5/24) As The Front Man

Mississippi Cannabis News1 year ago

Horn Lake denies cannabis dispensary request to allow sale of drug paraphernalia and Sunday sales | News

Hemp1 year ago

Press Release: CANNRA Calls for Farm Bill to Clarify Existing State Authority to Regulate Hemp Products

autoflower seeds8 months ago

5 best autoflower seed banks of 2024 by Leafly

Breaking News12 months ago

Nevada CCB to Accept Applications for Cannabis Establishments in White Pine County – “Only one cultivation and one production license will be awarded in White Pine County”

cannabis brands8 months ago

Discover New York’s dankest cannabis brands [September 2024]

Mississippi Cannabis News1 year ago

Local medical cannabis dispensary reacts to MSDH pulling Rapid Analytics License – WLBT

best list12 months ago

6 best CBD gummies of 2024 by Leafly

Arkansas8 months ago

The Daily Hit: October 2, 2024

best list11 months ago

5 best THC drinks of 2024 by Leafly

Mississippi Cannabis News1 year ago

People In This State Googled ‘Medical Marijuana’ The Most, Study Shows

Breaking News1 year ago

Weekly Update: Monday, May 13, 2024 including, New Guide for Renewals & May Board meeting application deadline

best list11 months ago

5 best delta-9 THC gummies of 2024 by Leafly

California Cannabis Updates1 year ago

Press Release: May 9, STIIIZY and Healing Urban Barrios hosted an Expungement Clinic & Second Chance Resource Fair

Breaking News1 year ago

PRESS RELEASE : Justice Department Submits Proposed Regulation to Reschedule Marijuana

Asia Pacific & Australia1 year ago

Thailand: Pro-cannabis advocates rally ahead of the government’s plan to recriminalize the plant

Trending